FingolimodUpper respiratory tract infection, neutropenia and infection: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1655卷 / 1期

关键词：

D O I：

10.1007/s40278-017-31194-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：115 / 115

相关论文

共 50 条

[1] CladribineFever, upper respiratory tract infection and neutropenia: 2 case reports
[J]. Reactions Weekly, 2021, 1840 (1) : 125 - 125
[2] NiraparibThrombocytopenia, neutropenia and urinary tract infection: 2 case reports
[J]. Reactions Weekly, 2019, 1775 (1) : 336 - 336
[3] TocilizumabVaricella infection and recurrent upper respiratory tract infection: 2 case reports
[J]. Reactions Weekly, 2017, 1649 (1) : 237 - 237
[4] TocilizumabVaricella infection and recurrent upper respiratory tract infection: 2 case reports
[J]. Reactions Weekly, 2017, 1674 (1) : 288 - 288
[5] BortezomibAcute lower respiratory tract infection: 2 case reports
[J]. Reactions Weekly, 2017, 1675 (1) : 60 - 60
[6] IguratimodOrbital cellulitis and respiratory tract infection: 2 case reports
[J]. Reactions Weekly, 2022, 1913 (1) : 246 - 246
[7] AntineoplasticsFusarium infection and neutropenia: 2 case reports
[J]. Reactions Weekly, 2016, 1594 (1) : 24 - 24
[8] InfliximabSinus bradycardia and upper respiratory tract infection: 2 case reports
[J]. Reactions Weekly, 2015, 1547 (1) : 159 - 159
[9] TofacitinibDiarrhoea and respiratory tract infection: 3 case reports
[J]. Reactions Weekly, 2019, 1749 (1) : 377 - 377
[10] RituximabUrinary tract infection caused by Escherichia coli and fatal respiratory infection: 2 case reports
[J]. Reactions Weekly, 2020, 1832 (1) : 260 - 260

← 1 2 3 4 5 →